Udayan Guha

Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial

Anish Thomas, Arun Rajan, Arlene Berman et al. · The Lancet Oncology · 2015 · 293 citations · Full text

Open-label Phase 2, Oncology, Clinical Trials +6

Molecular Profiling and Targeted Therapy for Advanced Thoracic Malignancies: A Biomarker-Derived, Multiarm, Multihistology Phase II Basket Trial

Ariel López-Chávez, Anish Thomas, Arun Rajan et al. · Journal of Clinical Oncology · 2015 · 234 citations

Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins

Marianne S. Poruchynsky, Edina Komlódi-Pásztor, Shana Y. Trostel et al. · Proceedings of the National Academy of Sciences · 2015 · 179 citations · Full text

Identification of <i>KIF5B-RET</i> and <i>GOPC-ROS1</i> Fusions in Lung Adenocarcinomas through a Comprehensive mRNA-Based Screen for Tyrosine Kinase Fusions

Yoshiyuki Suehara, Maria E. Arcila, Lu Wang et al. · Clinical Cancer Research · 2012 · 178 citations

A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer

Ronan J. Kelly, Anish Thomas, Arun Rajan et al. · Annals of Oncology · 2013 · 171 citations · Full text

Phase I/ii Study, Medicine, Pharmacology +8